Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.22 USD | +1.67% | +4.92% | -11.18% |
05-10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
05-08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MIRUM PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +1.67% | +4.92% | -11.18% | -6.12% | - | 1.24B |
Technical Rankings Surperformance
- Stock Market
- Equities
- MIRM Stock
- Charts Mirum Pharmaceuticals, Inc.
- Comparison Chart